Inborn and acquired von Willebrand disease;Angeborenes und erworbenes von-Willebrand-Syndrom

Hamostaseologie

Volumn 28, Issue 5, 2008, Pages 312-319

  Schneppenheim, Reinhard ^a   Budde, U ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Aesculabor   (Germany)

Author keywords

Von Willebrand disease; Von Willebrand syndrom

Indexed keywords

ANTIGEN; COLLAGEN; PROTEIN; VON WILLEBRAND FACTOR;

BIOSYNTHESIS; BLOOD LEVEL; CHEMICAL STRUCTURE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTORY; MOLECULAR GENETICS; PHENOTYPE; PHYSICIAN; PROTEIN DEGRADATION; REVIEW; VON WILLEBRAND DISEASE;

EID: 58149465019     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617179     Document Type: Review

References (35)

1. Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986; 43: 303-311.
2. Budde U, Drewke E, Will K et al. Standardisierte Diagnostik des von Willebrand-Syndroms. Hämostaseologie 2004; 24: 12-26.
3. Federici AB, Budde U, Rand JH. Acquired von Willebrand-syndrome 2004: International registry. Hämostaseologie 2004; 24: 50-55.
4. Federici AB, Canciani MT, Forza I et al.. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ib alpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89: 77-85.
5. Foster PA, Fulcher CA, Marti T et al. A major F VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 1987; 262: 8443-8446.
6. Fujimura Y, Titani K, Holland LZ et al. A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem 1987; 262: 1734-1739.
7. Ginsburg D, Handin RI, Bonthron DT et al. Human von Willebrand factor: isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-1406.
8. Holmberg L, Nilsson IM. Genetic variants of von Willebrand's disease. Br Med J 1972; 3: 317-320.
9. Ingerslev J, Hvitfeldt Poulsen L, Sørensen B. Current treatment of von willebrand's disease. Hämostaseologie 2004; 24: 56-64.
10. Kalafatis M, Takahashi Y, Girma JP et al. Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365. Blood 1987; 70: 1577-1583.
11. Lynch DC, Zimmerman TS, Collins CJ et al. Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell 1985; 41: 49-56.
12. Mancuso DJ, Tuley EA, Westfield LA et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-19527.
13. Mazurier C, Parquet Gernez A, Goudemand M. Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of von Willebrand's disease. Pathol Biol Paris 1977; 25: 18-24.
14. Miller MA, Palascak JE, Thompson MR et al. A modified SDS agarose gel method for determining factor VIII von Willebrand factor multimers using commercially available reagents. Thromb Res 1985; 39: 777-780.
15. Ruggeri ZM. Classification of von Willebrand disease. In: Verstraete M, Vermylen J, Lijnen R et al (eds). Thrombosis and Haemostasis 1987. Leuven: Leuven University Press 1987: 419-445.
16. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981; 57: 1140-1143.
17. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980; 65: 1318-1325.
18. Ruggeri ZM, Zimmerman TS. Von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904.
19. Ruggeri ZM. Platelet and von Willebrand factor interactions at the vessel wall. Hämostaseologie 2004; 24: 1-11.
20. Ruggeri ZM, Pareti FI, Mannucci PM et al. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980; 302: 1047-1051.
21. Sadler JE, Budde U, Eikenboom JC et al. Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-2114.
22. Sadler JE, Shelton-Inloes BB, Sorace JM et al. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985; 82: 6394-6398.
23. Sakariassen KS, Fressinaud E, Girma JP et al. Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor. Blood 1986; 67: 1515-1518.
24. Scharrer I. Women with von Willebrand disease. Hämostaseologie 2004; 24: 44-49.
25. Schneppenheim R, Budde U. Von Willebrand-Syndrom und von Willebrand-Faktor - Aktuelle Aspekte der Diagnostik und Therapie. 2. Aufl. Bremen: UNI-MED 2006.
26. Schneppenheim R, Budde U. Klassifikation des von-Willebrand-Syndroms. Hämostaseologie 2004; 24: 27-36.
27. Schneppenheim R, Plendl H, Budde U. Luminography - an alternative assay for detection of von Willebrand factor multimers. Thromb Haemost 1988; 60: 133-136.
28. Schneppenheim R. Molekulare Genetik des von Willebrand Syndroms. Hämostaseologie 2004; 24: 37-43.
29. Schneppenheim R, Budde U, Krey S et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost 1996; 764: 598-602.
30. Shulman J, Smith C H, Erlandson M et al. Vascular hemophilia. A familial hemorraghic disease in males and females characterized by combined antihemophilic globulin deficiency and vascular abnormalities. Pediatrics 1956; 18: 347.
31. Verweij CL, de-Vries CJ, Distel B et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Nucleic Acids Res 1985; 13: 4699-4717.
32. Von Willebrand EA, Jürgens R. Über ein neues vererbbares Blutungsübel: die konstitutionelle Thrombopathie. Dtsch Arch Klin Med 1933; 175: 453-483.
33. Von Willebrand EA. Hereditär pseudohemofili. Finska Läkaresällskapets Handlingar 1926; 672: 7-112.
34. Weiss HJ, Hoyer LW, Rickles FR et al. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 1973; 52: 2708-2716.
35. Zimmerman TS, Ratnoff OD, Powell AE. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's disease, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest 1971; 50: 244-254.